Indian LGBTQ+ groups push to widen access to HIV prevention drug PrEP
Every morning, Neharika Ravalkar takes a pill that stops her joining the millions of Indians who are HIV-positive. As a trans woman, Ravalkar is among the groups at highest risk of HIV. But she is among a lucky minority taking pre-exposure prophylaxis (PrEP) medication as cost, lack of awareness and stigma all hamper access in the South Asian nation. “PrEP is like a bodyguard for me,” said Ravalkar, who primarily scrapes a living from begging in Pune, western India “I’ve been helping people in my community to take it and…
Read More